Does BOTULINUM TOXIN TYPE A Cause Condition aggravated? 582 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 582 reports of Condition aggravated have been filed in association with BOTULINUM TOXIN TYPE A (Jeuveau). This represents 15.6% of all adverse event reports for BOTULINUM TOXIN TYPE A.
582
Reports of Condition aggravated with BOTULINUM TOXIN TYPE A
15.6%
of all BOTULINUM TOXIN TYPE A reports
529
Deaths
473
Hospitalizations
How Dangerous Is Condition aggravated From BOTULINUM TOXIN TYPE A?
Of the 582 reports, 529 (90.9%) resulted in death, 473 (81.3%) required hospitalization, and 472 (81.1%) were considered life-threatening.
Is Condition aggravated Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BOTULINUM TOXIN TYPE A. However, 582 reports have been filed with the FAERS database.
What Other Side Effects Does BOTULINUM TOXIN TYPE A Cause?
Off label use (1,785)
Drug ineffective (1,175)
Drug intolerance (1,004)
Product use in unapproved indication (950)
Headache (797)
Migraine (775)
Maternal exposure during pregnancy (716)
Pain (714)
Hypoaesthesia (703)
Nausea (665)
What Other Drugs Cause Condition aggravated?
TOFACITINIB (16,925)
INFLIXIMAB (16,616)
DUPILUMAB (16,459)
ETANERCEPT (15,897)
METHOTREXATE (14,938)
ADALIMUMAB (13,527)
PREDNISONE (10,751)
INFLIXIMAB-DYYB (10,275)
HYDROXYCHLOROQUINE (8,848)
RITUXIMAB (8,627)
Which BOTULINUM TOXIN TYPE A Alternatives Have Lower Condition aggravated Risk?
BOTULINUM TOXIN TYPE A vs BREMELANOTIDE
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB VEDOTIN
BOTULINUM TOXIN TYPE A vs BREO ELLIPTA
BOTULINUM TOXIN TYPE A vs BREXANOLONE